The claim that women possess a sharper sense of smell than men is one of those folk observations that turns out to be approximately correct, repeatedly replicated, and yet rarely explained with any mechanical honesty. The figure most often quoted in popular science writing — that women’s olfactory sensitivity runs roughly 50 percent higher than men’s — is defensible in the narrow sense that odour detection thresholds, identification accuracy, and discrimination tasks consistently favour women across age groups, cultures, and testing protocols. The figure is also, on close examination, an averaged shorthand for a much messier underlying biology.
The standard cultural framing tends to treat this difference as either a charming quirk or a vague evolutionary just-so story about mothers detecting spoiled food. That framing is approximately right in its emotional effect and badly incomplete in its mechanics. The actual mechanism involves cell counts in the olfactory bulb, hormonal modulation of receptor sensitivity, and a pregnancy-specific amplification that some evolutionary biologists have argued — with varying degrees of confidence — functions as a chemical defence system for the developing fetus.
What the headline number is actually measuring
The 50 percent figure is a composite. It draws from olfactory threshold tests (the lowest concentration at which an odour can be reliably detected), identification tests (naming a smell from a fixed list), and discrimination tests (telling two similar odorants apart). Women outperform men on all three, but the size of the gap depends heavily on the odorant tested, the menstrual phase of the participants, and the age cohort.
The part worth slowing down on is that cell counts do not fully explain the behavioural gap. Women score better even when controlling for bulb size, which points toward a second factor: hormones.
The hormonal scaffolding underneath
Olfactory receptors are modulated by oestrogen and, to a lesser extent, progesterone. The receptors themselves are expressed in nasal epithelium, but their downstream processing in the limbic system and orbitofrontal cortex is gated by hormonal state. Women’s odour sensitivity shifts measurably across the menstrual cycle, peaking around ovulation, when oestrogen is highest. Post-menopausal women, with sharply reduced oestrogen, lose much of the advantage over age-matched men. The same hormonal architecture that produces sex differences in pain perception appears to be operating, in modified form, in the olfactory system.
This matters for the pregnancy claim. Pregnancy is, in hormonal terms, an oestrogen and progesterone event of extraordinary magnitude. Circulating oestrogen during the third trimester runs roughly 100 times higher than baseline levels in a non-pregnant woman. Progesterone climbs to levels not seen outside pregnancy. If olfactory sensitivity is hormonally modulated in the ordinary cycle, the pregnancy state represents a hormonal regime so extreme that any modulation effect should, in principle, be amplified considerably.
The empirical evidence broadly supports this prediction, though with caveats. First-trimester pregnant women consistently report heightened sensitivity to odours, particularly food smells, cooking aromas, and what researchers loosely group as “spoilage cues” — fermented, rotting, or chemically degraded materials. Self-report studies are notoriously unreliable on absolute thresholds, but controlled testing has shown measurable, if modest, increases in detection sensitivity for specific odorant classes during early pregnancy.
The defence hypothesis, stated carefully
The evolutionary argument is older than is usually acknowledged. Margie Profet proposed in the early 1990s that pregnancy sickness — the nausea, food aversions, and odour hypersensitivity characteristic of the first trimester — functioned as an adaptive system to protect the developing embryo from teratogens and pathogens in the maternal diet. The embryonic period, roughly weeks three through eight after conception, is when organogenesis occurs and when the fetus is most vulnerable to chemical damage. It is also precisely the window in which morning sickness peaks.
The logic of the hypothesis is straightforward. A pregnant woman whose nose becomes hypersensitive to bitter alkaloids, microbial volatiles, and meat off-notes is a woman more likely to reject foods that carry teratogenic plant toxins or bacterial loads. The adaptation does not need to be perfect or universal to be evolutionarily favoured; it only needs to have reduced fetal mortality on average across deep evolutionary time. The framing has been refined over subsequent decades, with researchers at the University of California and elsewhere examining the patterning of food aversions and finding that they cluster around exactly the categories the defence hypothesis predicts: meat, fish, eggs, strong vegetables, and beverages with high microbial or alkaloid loads.
The hypothesis is not unanimously accepted. A 2025 analysis from UCLA researchers linked morning sickness more directly to inflammatory responses triggered by the body’s reaction to placental and fetal biological signals, suggesting that the response complex may be a by-product of immune adjustment rather than a purpose-built defence. The two framings are not strictly incompatible — an inflammatory response could itself have been co-opted by selection because it produced aversive behaviours with protective consequences — but the mechanistic emphasis differs.
What the placenta has to do with it
The deeper evolutionary context has come into focus only recently. An international team led by researchers at the University of Vienna published findings in 2025 on the evolutionary history of the placenta, tracing the specialized cell types at the maternal–fetal interface back roughly 100 million years. The placenta is, on close examination, a negotiated boundary — a structure that allows the fetus to draw nutrients from the mother while suppressing the immune rejection that would otherwise treat fetal tissue as foreign.
According to the researchers, this cell-level dialogue highlights that the relationship between mother and fetus is a dynamic history of co-evolution, where both compartments continuously adapt to balance resource allocation and mutual survival.
Historical research on complex conditions like preeclampsia sits in the same broad theoretical territory: pregnancy as a state of layered, sometimes contradictory adaptations, where maternal physiology has been reshaped by selection pressures operating on fetal survival. The defence framing of heightened smell fits naturally into this picture, even if the specific causal pathway is still being worked out.
What the evidence does not support
Several stronger claims that circulate alongside the basic finding do not hold up. The idea that pregnant women can smell things genuinely undetectable to other adults — that the threshold shift is qualitative rather than quantitative — is not well supported. The effect is real but modest in absolute terms; what changes more dramatically is the hedonic response, the degree to which a given smell is experienced as aversive or nauseating.
The claim that the pregnancy effect is universal also does not survive scrutiny. A meaningful minority of pregnant women report no notable change in smell sensitivity, and some report reduced sensitivity in later trimesters. The averaged effect is real; the individual variance is substantial.
And the strongest version of the defence hypothesis — that olfactory hypersensitivity evolved specifically as a fetal protection mechanism — remains a hypothesis, not a settled finding. The pattern of food aversions is consistent with the prediction. The hormonal timing is consistent with the prediction. The fetal vulnerability window is consistent with the prediction. None of this constitutes proof, and the inflammatory-response account offers a competing mechanism that would produce similar outputs through a different causal route.
What the corrected framing reveals
The honest version of the claim is more interesting than the headline. Women’s olfactory advantage is built on measurably more neural hardware in the olfactory bulb, modulated continuously by reproductive hormones, and amplified during pregnancy by a hormonal regime more extreme than any other natural human state. The amplification correlates with the period of maximum fetal vulnerability and produces changes — food aversions, nausea, avoidance of microbially and chemically loaded foods — that align with what a fetal defence system would, in principle, do.
Whether selection actually shaped the system for that purpose or whether the pattern is a side effect of inflammatory and hormonal adjustments that happened to be useful is, at present, an open question. The mechanism is real. The function is debated. The version of this story that a working biologist can defend is not “women smell better because they evolved to protect babies.” The version a biologist can defend is that there is a measurable sex difference in olfactory architecture, a hormonal modulation system that amplifies it during pregnancy, an output that resembles a defence mechanism, and a still-unresolved argument about whether that resemblance reflects design or coincidence. The arithmetic of the sensitivity gap is unforgiving; the evolutionary interpretation is not yet settled.
